UK hydroxychloroquine COVID-19 clinical trials to suspend recruitment

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued instructions for all UK clinical trials using hydroxychloroquine to treat or prevent COVID-19 to stop recruiting further participants.

This decision follows advice from the MHRA’s Commission on Human Medicines, which met in early June 2020 and reviewed the data that had been submitted for each trial. Read more at The Pharmaceutical Journal